Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry.
Charlotte DurringtonJudith A HurdmanCharlie A ElliotRhona MacleanJoost Van VeenGiorgia SaccculloDuneesha De-FoneskaAndrew J SwiftSmitha RajaramCatherine HillSteven ThomasKrit DwivediSamer AlabedJames M WildAthanasios CharalampopoulosAbdul G HameedAlexander M K RothmanLisa WatsonNeil HamiltonAlfred Arthur Roger ThompsonRobin CondliffeDavid G KielyPublished in: The European respiratory journal (2024)
In the real world setting a dedicated PE follow-up pathway identifies patients with less severe CTEPH and increases population-based CTEPH diagnostic and pulmonary endarterectomy rates. At the time of acute PE diagnosis the absence of major transient risk factors, CT features of pulmonary hypertension and chronic thromboembolism are risk factors for a subsequent diagnosis of CTEPH.
Keyphrases
- pulmonary hypertension
- pulmonary embolism
- drug induced
- pulmonary artery
- risk factors
- pulmonary arterial hypertension
- genome wide
- inferior vena cava
- early onset
- liver failure
- computed tomography
- coronary artery bypass grafting
- respiratory failure
- magnetic resonance imaging
- image quality
- contrast enhanced
- cerebral ischemia
- intensive care unit
- hepatitis b virus
- extracorporeal membrane oxygenation